TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.180
+0.040 (3.51%)
At close: Jan 7, 2026, 4:00 PM EST
1.170
-0.010 (-0.85%)
After-hours: Jan 7, 2026, 5:59 PM EST
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $66.96 million as of January 7, 2026. Its market cap has decreased by -59.14% in one year.
Market Cap
66.96M
Enterprise Value
-23.57M
1-Year Change
-59.14%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $66.96M, a decrease of -81.35%. That is a compound annual growth rate of -31.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 64.69M | 14.00% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |